Yoonkyung Park Selected Research

cefpiramide

9/2010

Antibiotic and synergistic effect of Leu-Lys rich peptide against antibiotic resistant microorganisms isolated from patients with cholelithiasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoonkyung Park Research Topics

Disease

20	Infections 01/2023 - 11/2006
8	Inflammation (Inflammations) 08/2022 - 08/2011
5	Bacterial Infections (Bacterial Infection) 12/2023 - 01/2011
5	Neoplasms (Cancer) 03/2018 - 07/2002
5	Hemolysis 06/2012 - 02/2005
3	Communicable Diseases (Infectious Diseases) 10/2022 - 04/2002
3	Gallstones (Gallstone) 09/2010 - 08/2004
2	Muscle Cramp (Cramp) 12/2022 - 03/2021
2	Septic Shock (Toxic Shock Syndrome) 10/2022 - 01/2016
2	Wounds and Injuries (Trauma) 12/2018 - 10/2017
2	Stomach Neoplasms (Stomach Cancer) 01/2018 - 01/2014
2	Cholelithiasis 01/2014 - 09/2010
2	Virus Diseases (Viral Diseases) 11/2006 - 06/2006
1	Cross Infection (Nosocomial Infection) 12/2023
1	Sepsis (Septicemia) 12/2023
1	Fibrosis (Cirrhosis) 12/2023
1	Herpes Zoster 12/2022
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 12/2022
1	Hepatitis B 08/2022
1	Chronic Hepatitis B 08/2022
1	Abscess 10/2021
1	Staphylococcal Infections 10/2021
1	Rheumatoid Arthritis 03/2021
1	COVID-19 12/2020
1	Vascular Calcification 03/2019
1	Rupture 01/2019
1	Pseudomonas Infections 12/2018
1	Skin Diseases (Skin Disease) 03/2018
1	Necrosis 01/2018
1	Colonic Neoplasms (Colon Cancer) 01/2018
1	Burns 10/2017
1	Body Weight (Weight, Body) 01/2016
1	Tuberculosis (Tuberculoses) 01/2015
1	Acne Vulgaris 01/2015
1	Gastritis 01/2014

Drug/Important Bio-Agent (IBA)

20	Antimicrobial PeptidesIBA 12/2023 - 08/2004
18	Anti-Bacterial Agents (Antibiotics)IBA 12/2023 - 07/2002
18	Peptides (Polypeptides)IBA 12/2022 - 04/2002
4	CytokinesIBA 12/2023 - 11/2018
4	Proteins (Proteins, Gene)FDA Link 08/2022 - 11/2006
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021 - 11/2018
3	Carbapenems (Carbapenem Antibiotics)IBA 12/2023 - 01/2022
3	Interleukin-6 (Interleukin 6)IBA 10/2021 - 10/2017
3	Adenosine Monophosphate (AMP)IBA 10/2017 - 01/2014
2	Adenosine Triphosphatases (ATPase)IBA 12/2022 - 12/2021
2	Peptide Hydrolases (Proteases)FDA Link 12/2022 - 02/2012
2	CathelicidinsIBA 12/2022 - 03/2021
2	Anti-Infective Agents (Microbicides)IBA 10/2022 - 03/2018
2	AcidsIBA 12/2021 - 01/2006
2	Nucleic AcidsIBA 01/2020 - 01/2019
2	LigandsIBA 03/2019 - 01/2019
2	Ciprofloxacin (Cipro)FDA LinkGeneric 12/2018 - 01/2014
2	APTIBA 10/2017 - 10/2016
2	ribosomal protein L1IBA 06/2012 - 01/2006
1	barium chloride (barium dichloride)IBA 12/2022
1	CalpainIBA 12/2022
1	CardiotoxinsIBA 12/2022
1	Hemolysin Proteins (Hemolysins)IBA 08/2022
1	Protein AggregatesIBA 08/2022
1	Hepatitis B e AntigensIBA 08/2022
1	hylinIBA 08/2022
1	Oxacillin (Prostaphlin)FDA LinkGeneric 01/2022
1	Nitric Oxide Synthase (NO Synthase)IBA 10/2021
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 10/2021
1	Cell-Penetrating PeptidesIBA 10/2021
1	Small Interfering RNA (siRNA)IBA 03/2021
1	VaccinesIBA 12/2020
1	A-factor (Streptomyces)IBA 11/2019
1	OsteoprotegerinIBA 03/2019
1	pleurocidinIBA 02/2019
1	InterferonsIBA 11/2018
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 11/2018
1	EndotoxinsIBA 04/2018
1	TubulinIBA 03/2018
1	ElastinIBA 03/2018
1	CollagenIBA 03/2018
1	HMGB1 Protein (HMG1)IBA 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 01/2018
1	Tigecycline (Tygacil)FDA Link 01/2018
1	Bortezomib (Velcade)FDA Link 01/2018
1	Proteasome InhibitorsIBA 01/2018
1	Meropenem (Merrem)FDA LinkGeneric 01/2018
1	Interleukin-8 (Interleukin 8)IBA 10/2017
1	Nucleotide AptamersIBA 10/2017
1	GoldIBA 10/2017
1	LipopolysaccharidesIBA 01/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016
1	peroxisome-proliferator-activated receptor-gamma coactivator-1IBA 11/2015
1	AnticoagulantsIBA 03/2015
1	CarbohydratesIBA 03/2015
1	AntioxidantsIBA 03/2015
1	Antimalarials (Antimalarial Agents)IBA 01/2015
1	Antiviral Agents (Antivirals)IBA 01/2015
1	Ampicillin (Omnipen)FDA LinkGeneric 01/2014
1	NF-kappa B (NF-kB)IBA 01/2014
1	Tobramycin (Nebcin)FDA LinkGeneric 01/2014
1	Cefotaxime (Kendrick)FDA LinkGeneric 01/2014
1	Erythromycin (Erycette)FDA LinkGeneric 01/2014

Therapy/Procedure

2	Therapeutics 10/2016 - 01/2015
1	Intra-Articular Injections 03/2021